Stockscreener 앱 받기
2.68
0.00%
0.00
시간 외 거래:
2.70
0.02
+0.75%
전일 마감가:
$2.68
열려 있는:
$2.66
하루 거래량:
1.82M
Relative Volume:
0.75
시가총액:
$909.68M
수익:
$775.09M
순이익/손실:
$-58.68M
주가수익비율:
-20.21
EPS:
-0.1326
순현금흐름:
$64.06M
1주 성능:
-4.29%
1개월 성능:
-2.90%
6개월 성능:
-43.70%
1년 성능:
-39.37%
1일 변동 폭
$2.63
$2.745
1주일 범위
$2.63
$2.9599
52주 변동 폭
$2.61
$5.8099
Goodrx Holdings Inc Stock (GDRX) Company Profile
명칭
Goodrx Holdings Inc
전화
(855) 268-2822
주소
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
2.68 | 909.68M | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
222.21 | 35.99B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
70.33 | 12.26B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
41.26 | 7.73B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
85.37 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.20 | 7.14B | 11.99B | 24.18M | 234.31M | 0.2956 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Underweight |
| 2025-08-11 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2024-12-04 | 개시 | Mizuho | Neutral |
| 2024-08-09 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-02 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2023-08-10 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2023-07-31 | 업그레이드 | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 개시 | Citigroup | Buy |
| 2022-11-04 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-12 | 개시 | DA Davidson | Neutral |
| 2022-06-10 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-06-06 | 재개 | BofA Securities | Buy |
| 2022-06-01 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-05-10 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 개시 | Wells Fargo | Equal Weight |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-15 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 재확인 | Barclays | Overweight |
| 2022-03-01 | 재확인 | BofA Securities | Neutral |
| 2022-03-01 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-03-01 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 재확인 | Evercore ISI | Outperform |
| 2022-03-01 | 재확인 | Goldman | Buy |
| 2022-03-01 | 재확인 | JP Morgan | Underweight |
| 2022-03-01 | 재확인 | RBC Capital Mkts | Outperform |
| 2022-03-01 | 재확인 | SVB Leerink | Outperform |
| 2022-01-07 | 개시 | Goldman | Buy |
| 2021-12-21 | 개시 | Stephens | Overweight |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-08-31 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2021-08-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-06 | 재개 | Evercore ISI | Outperform |
| 2021-01-25 | 개시 | Guggenheim | Buy |
| 2020-11-19 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 개시 | Barclays | Equal Weight |
| 2020-10-19 | 개시 | BofA Securities | Neutral |
| 2020-10-19 | 개시 | Citigroup | Buy |
| 2020-10-19 | 개시 | Cowen | Outperform |
| 2020-10-19 | 개시 | Credit Suisse | Outperform |
| 2020-10-19 | 개시 | Deutsche Bank | Hold |
| 2020-10-19 | 개시 | Goldman | Neutral |
| 2020-10-19 | 개시 | JP Morgan | Neutral |
| 2020-10-19 | 개시 | Morgan Stanley | Overweight |
| 2020-10-19 | 개시 | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 개시 | SVB Leerink | Outperform |
| 2020-10-19 | 개시 | UBS | Buy |
모두보기
Goodrx Holdings Inc 주식(GDRX)의 최신 뉴스
GoodRx (NASDAQ:GDRX) Upgraded at Wall Street Zen - MarketBeat
Aug Swings: What is the next catalyst for GoodRx Holdings IncJuly 2025 Drop Watch & Daily Price Action Insights - baoquankhu1.vn
Recap Report: What is the next catalyst for GoodRx Holdings IncBreakout Watch & Community Consensus Trade Alerts - baoquankhu1.vn
GoodRx CEO on TrumpRx and Surescripts Partnership - marketscreener.com
Performance Recap: Will GoodRx Holdings Inc stock deliver shareholder valueJuly 2025 Update & Consistent Return Investment Signals - Bộ Nội Vụ
Drug price tool shows pharmacy costs upfront with GoodRx savings - Stock Titan
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 64.56% Potential Upside for Investors - DirectorsTalk Interviews
BofA maintains underperform rating on GoodRx (GDRX) while trimming PT to $2.60 - MSN
BofA Maintains Underperform Rating on GoodRx (GDRX) While Trimming PT to $2.60 - Insider Monkey
Citigroup Maintains Buy Rating on GoodRx (GDRX) but Lowers Price Target | GDRX Stock News - GuruFocus
Citigroup Has Lowered Expectations for GoodRx (NASDAQ:GDRX) Stock Price - MarketBeat
GoodRx Holdings (FRA:8GH) 3-Year RORE % : 57.89% (As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Days Inventory : 0.00 (As of Sep. 2025) - GuruFocus
Enterprise value to EBITDA ratio of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
GoodRx Holdings (FRA:8GH) EPS (Basic) : €0.09 (TTM As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Common Stock : €0.0 Mil (As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) EV-to-Revenue : 1.30 (As of Jan. 09, 2026) - GuruFocus
How supply chain issues affect GoodRx Holdings Inc. stockTrade Performance Summary & Weekly Breakout Opportunity Watchlist - ulpravda.ru
Can GoodRx Holdings Inc. stock deliver strong Q4 earningsJuly 2025 Opening Moves & Free Fast Entry Momentum Trade Alerts - Улправда
What Wall Street predicts for GoodRx Holdings Inc. stock priceJuly 2025 Macro Moves & Expert Verified Stock Movement Alerts - Улправда
GoodRx Holdings (FRA:8GH) Interest Income : €13.6 Mil (TTM As of Sep. 2025) - GuruFocus
Aug Wrap: Is GoodRx Holdings Inc. stock positioned for digital transformationIPO Watch & Daily Profit Maximizing Trade Tips - Улправда
Is GoodRx Holdings Inc. stock positioned for digital transformationIPO Watch & Daily Profit Maximizing Trade Tips - ulpravda.ru
GoodRx Holdings Inc (FRA:8GH) Stock Earnings Transcripts - GuruFocus
Who's Buying or Selling GoodRx Holdings Inc (FRA:8GH) Stock Today? - GuruFocus
GoodRx Holdings (FRA:8GH) Days Sales Outstanding - GuruFocus
GoodRx Holdings (FRA:8GH) Price-to-Owner-Earnings : 26.89 (As of Jan. 09, 2026) - GuruFocus
GoodRx Holdings (FRA:8GH) Treasury Stock : €0.0 Mil (As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Purchase Of Business : €-30.0 Mil (TTM As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) EPS without NRI - GuruFocus
GoodRx Holdings (FRA:8GH) EPS (Diluted) : €0.09 (TTM As of Sep. 2025) - GuruFocus
GoodRx Holdings Inc Stock Operating Data - GuruFocus
GoodRx Holdings (FRA:8GH) Issuance of Stock : €0.0 Mil (TTM As of Sep. 2025) - GuruFocus
GoodRx Holdings (FRA:8GH) Profitability Rank : 4 (As of Sep. 2025) - GuruFocus
GoodRx Holdings Inc (FRA:8GH) Stock News, Headlines & Updates - GuruFocus
GoodRx Holdings (FRA:8GH) 10-Year RORE % : 0.00% (As of Sep. 2025) - GuruFocus
Can GoodRx Holdings Inc. stock surprise with earnings upsideJuly 2025 Spike Watch & Target Return Focused Picks - Улправда
Why GoodRx Holdings Inc. stock could outperform in 2025Trade Exit Summary & Accurate Technical Buy Alerts - ulpravda.ru
Is GoodRx Holdings Inc. stock a safe buy before earningsForecast Cut & High Conviction Buy Zone Alerts - Улправда
Scan a code at Giant Eagle to unlock cheaper Ozempic and Wegovy - Stock Titan
Q3 2025 GoodRx Holdings Inc Earnings Call Transcript - GuruFocus
GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring A 71.61% Upside Potential - DirectorsTalk Interviews
Novo Nordisk's Wegovy Weight Loss Pill Hits US Pharmacies With Lower Starting Cost - Benzinga
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds By Investing.com - Investing.com South Africa
GoodRx stock price target lowered to $2.60 at BofA on pharmacy headwinds - Investing.com
GoodRx Holdings Inc. (GDRX) PT Lowered to $2.60 at BofA Securities, Underperofrm, 'We Remain Cautious' - StreetInsider
New Wegovy weight-loss pill now $149 a month through GoodRx - Stock Titan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Preferred dividends of GoodRx Holdings, Inc. Class A – FWB:8GH - TradingView — Track All Markets
Pacer Advisors Inc. Makes New Investment in GoodRx Holdings, Inc. $GDRX - MarketBeat
GoodRx Holdings And 2 Other Compelling Penny Stocks To Consider - Yahoo Finance
Goodrx Holdings Inc (GDRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
3.21%
2.88%
자본화:
|
볼륨(24시간):